Contact Us Suppport HCC Webmail
ADVERTISEMENT

Custom Search
Today's Health Headlines
(Reuters) - Iowa on Monday withdrew a request to waive some Obamacare rules to help shore up its struggling healthcare insurance market, marking a setback in efforts by Republican-governed states to sidestep requirements of the Obama-era law.

LONDON (Reuters) - An unlisted Swiss biotech company focused on developing "armed antibodies" to fight cancer has raised $200 million in a funding round backed by AstraZeneca and other private backers.

(Reuters) - The U.S. Food and Drug Administration said on Monday it issued a warning letter to Meridian Bioscience Inc's unit for several federal law violations after inspecting its facility that makes lead-testing devices.

SAO PAULO (Reuters) - Health authorities launched a yellow fever vaccination campaign on the north side of Brazil's largest city over the weekend after a dead monkey was found infected with the disease, state and city officials said on Monday.

PARIS (Reuters) - Bulgaria has reported two outbreaks of the highly pathogenic H5 bird flu virus, the Paris-based World Organisation for Animal Health (OIE) said on Monday.

LONDON (Reuters) - GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects approval this year.

(Reuters Health) - People with fewer assets like real estate, savings, stocks and retirement accounts may be more likely to develop disabilities or die prematurely than wealthier individuals, a new study suggests.

(Reuters Health) - Teens who vape, or use e-cigarettes, may be more likely to develop a regular smoking habit when the liquid they use in their vaping devices has higher concentrations of nicotine, a U.S. study suggests.

(Reuters Health) - A newborn girl in Canada developed a life-threatening infection after being delivered in a hot tub, according to a case report that some doctors say offers fresh evidence that women should not deliver babies in water.

ZURICH (Reuters) - Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery.

Welcome Guest
Username: 
Password:
Not a member? Sign Up!
Browse RSS Feeds
click here when finished
Save Page Layout
Video
loading